Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes. (Q51558660)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes. |
scientific article |
Statements
1 reference
Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes. (English)
1 reference
Ebeling P
1 reference
Teppo AM
1 reference
Koistinen HA
1 reference
Viikari J
1 reference
Rönnemaa T
1 reference
Nissén M
1 reference
Bergkulla S
1 reference
Salmela P
1 reference
Saltevo J
1 reference
Koivisto VA
1 reference
1 December 1999
1 reference
1 reference
42
1 reference
12
1 reference
1433-1438
1 reference
Identifiers
1 reference